BAX Straddle Strategy
BAX (Baxter International Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
BAX (Baxter International Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $8.94B, a beta of 0.62 versus the broader market, a 52-week range of 15.73-32.04, average daily share volume of 9.1M, a public-listing history dating back to 1981, approximately 38K full-time employees. These structural characteristics shape how BAX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates BAX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. BAX pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a straddle on BAX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current BAX snapshot
As of May 15, 2026, spot at $17.30, ATM IV 43.85%, IV rank 40.58%, expected move 12.57%. The straddle on BAX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this straddle structure on BAX specifically: BAX IV at 43.85% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 12.57% (roughly $2.17 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BAX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BAX should anchor to the underlying notional of $17.30 per share and to the trader's directional view on BAX stock.
BAX straddle setup
The BAX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BAX near $17.30, the first option leg uses a $17.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BAX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BAX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $17.50 | $0.80 |
| Buy 1 | Put | $17.50 | $0.90 |
BAX straddle risk and reward
- Net Premium / Debit
- -$170.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$163.43
- Breakeven(s)
- $15.80, $19.20
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
BAX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on BAX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | +$1,579.00 |
| $3.83 | -77.8% | +$1,196.60 |
| $7.66 | -55.7% | +$814.20 |
| $11.48 | -33.6% | +$431.79 |
| $15.31 | -11.5% | +$49.39 |
| $19.13 | +10.6% | -$6.99 |
| $22.95 | +32.7% | +$375.41 |
| $26.78 | +54.8% | +$757.81 |
| $30.60 | +76.9% | +$1,140.22 |
| $34.43 | +99.0% | +$1,522.62 |
When traders use straddle on BAX
Straddles on BAX are pure-volatility plays that profit from large moves in either direction; traders typically buy BAX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
BAX thesis for this straddle
The market-implied 1-standard-deviation range for BAX extends from approximately $15.13 on the downside to $19.47 on the upside. A BAX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current BAX IV rank near 40.58% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on BAX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BAX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BAX-specific events.
BAX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BAX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BAX alongside the broader basket even when BAX-specific fundamentals are unchanged. Always rebuild the position from current BAX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on BAX?
- A straddle on BAX is the straddle strategy applied to BAX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With BAX stock trading near $17.30, the strikes shown on this page are snapped to the nearest listed BAX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BAX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the BAX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 43.85%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$163.43 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BAX straddle?
- The breakeven for the BAX straddle priced on this page is roughly $15.80 and $19.20 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BAX market-implied 1-standard-deviation expected move is approximately 12.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on BAX?
- Straddles on BAX are pure-volatility plays that profit from large moves in either direction; traders typically buy BAX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current BAX implied volatility affect this straddle?
- BAX ATM IV is at 43.85% with IV rank near 40.58%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.